Depreciation Amortization - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gensight Biologics SA
Depreciation & Amortization Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Depreciation & Amortization
€2.2m
CAGR 3-Years
33%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Depreciation & Amortization
€27.1m
CAGR 3-Years
34%
CAGR 5-Years
30%
CAGR 10-Years
8%
Nanobiotix SA
PAR:NANO
Depreciation & Amortization
€1.5m
CAGR 3-Years
-5%
CAGR 5-Years
20%
CAGR 10-Years
21%
Innate Pharma SA
PAR:IPH
Depreciation & Amortization
€2.6m
CAGR 3-Years
-63%
CAGR 5-Years
-26%
CAGR 10-Years
5%
Genfit SA
NASDAQ:GNFT
Depreciation & Amortization
€1.7m
CAGR 3-Years
-23%
CAGR 5-Years
-2%
CAGR 10-Years
13%
Eurobio Scientific SA
PAR:ALERS
Depreciation & Amortization
€14.2m
CAGR 3-Years
25%
CAGR 5-Years
18%
CAGR 10-Years
20%

See Also

What is Gensight Biologics SA's Depreciation & Amortization?
Depreciation & Amortization
2.2m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Depreciation & Amortization amounts to 2.2m EUR.

What is Gensight Biologics SA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
47%

Over the last year, the Depreciation & Amortization growth was 105%. The average annual Depreciation & Amortization growth rates for Gensight Biologics SA have been 33% over the past three years , 47% over the past five years .

Back to Top